期刊文献+

非小细胞肺癌p53凋亡刺激蛋白家族表达临床研究 被引量:5

Expression of apoptosis stimulating protein of P53 in non-small cell lung cancer
原文传递
导出
摘要 目的:探讨非小细胞肺癌p53凋亡刺激蛋白家族(apoptosis-sti mulating protein of p53,ASPP)1,ASPP2mRNA表达与P53蛋白表达状态的关系及ASPP1,ASPP2 mRNA的表达与非小细胞肺癌发生的相关性。方法:应用实时荧光定量RT-PCR方法检测37例非小细胞肺癌患者癌组织、癌旁组织、正常肺组织ASPP1,ASPP2 mRNA表达,免疫组织化学法检测肺癌组织P53蛋白表达状态。结果:肺癌组织、癌旁组织、正常肺组织中ASPP1、ASPP2 mRNA表达均逐渐升高,肺癌组织ASPP1,ASPP2 mRNA表达低于癌旁组织和正常肺组织(P<0.05),癌旁组织和正常肺组织ASPP1、ASPP2 mRNA表达差异无统计学意义(P>0.05)。肺癌组织中ASPP1,ASPP2 mRNA表达在P53阴性组中明显低于P53阳性组(P<0.05)。结论:肺癌组织ASPP1、ASPP2 mRNA表达降低与非小细胞肺癌的发生密切相关,ASPP mRNA的表达可在基因水平检测肿瘤的发生。 Objective To investigate the relationship of the expressions of ASPP1 and ASPP2 mRNA with the expression of P53 in non-small cell lung cancer and to explore the correlation of the expressions of ASPP1 and ASPP2 mRNA with the development of non-small cell lung cancer.Methods The expressions of ASPP1 and ASPP2 mRNA were detected in non-small cell lung cancer tissue,paracarcinomatous tissue and normal lung tissue with real-time fluorescence quantitative RT-PCR,and the expression of P53 was observed with immunohistochemistry staining.Results The expression levels of ASPP1 and ASPP2 mRNA in non-small cell lung cancer tissue,paracarcinomatous tissue and normal lung tissue increased gradually.The levels of ASPP1 and ASPP2 mRNA in cancer tissue were lower than those in paracarcinomatous tissue and normal lung tissue.The levels of ASPP1 and ASPP2 mRNA in negative P53 cancer tissue were significantly lower than those in positive P53 cancer tissue respectively.There was no significant difference in the expressions of ASPP1 and ASPP2 mRNA between paracarcinomatous tissue and normal lung tissue.Conclusion The decreased levels of ASPP1 and ASPP2 mRNA expression in non-small cell lung cancer tissue are closely correlated to the development of non-small cell lung cancer.ASPP mRNA expression can detect the development of tumor at the genetic level.
出处 《中华实用诊断与治疗杂志》 2010年第11期1060-1062,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 辽宁省教育厅科研基金资助项目(2009A188)
关键词 非小细胞肺癌 p53凋亡刺激蛋白 P53蛋白 Non-small cell lung cancer ASPP P53 protein
  • 相关文献

参考文献10

  • 1Haupt S, Berger M, Goldberg Z, et al. Apoptosis:the p53 network[J]. J Cell Sci,2003,116(20) :4077 -4085.
  • 2Bergamaschi D, Samuels, O'Neil N J, et al. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human[J]. Nat Genet,2003,33(2) :162-167.
  • 3Tammemagi M C, McLaughlin J R, Bull S B. Meta analyses of p53 tumor suppressor gene alterations and clinicopathologlcal features in resected lung cancer [J ]. Cancer Epidemiol Biomarkers Prev, 1999,8(7): 625-634.
  • 4冯雪凤,许守林,施鸣,郭万华.^(99m)Tc-MDP骨扫描和肿瘤标记物在不同组织类型肺癌中的意义[J].中华实用诊断与治疗杂志,2008,22(10):742-744. 被引量:6
  • 5Mitsudomi T, Hamajima N, Ogava M, et al. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis[J]. Clin Cancer Res,2000,6(10):4055- 4063.
  • 6Bergamaschi D, Samuels Y, Jin B, et al. ASPP1 and ASPP2: common activators of p53 family members[J]. Mol Cell Biol, 2004,24(3) : 1341-1350.
  • 7Lossos I S, Natkunam Y, Levy R, et al. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma; correlation with clinical outcome [J]. Leuk Lymphoma,2002,43(12) :2309-2317.
  • 8苏胜发,卢冰,苏敏,李大中,何常,钟愉.非小细胞肺癌中ASPP1、ASPP2蛋白的不同表达状态及其意义[J].肿瘤预防与治疗,2008,21(2):123-126. 被引量:6
  • 9Brambilla E, Gazzeri S, Moro D, et al. Immunohistochemical study of p53 in human lung carcinomas[J]. Am J Pathol, 1993, 143(1) :199-210.
  • 10孙彬,张云.ASPP1基因mRNA在肿瘤细胞株中的表达初探[J].解放军医学杂志,2008,33(9):1096-1097. 被引量:4

二级参考文献27

  • 1张昕,张湘茹.肺癌肿瘤标志物的临床价值[J].癌症进展,2005,3(2):159-162. 被引量:42
  • 2杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 3高云,方健,刘叙仪,林宝和,安彤同,高非.305例非小细胞肺癌骨转移的诊断、治疗及预后分析[J].中国肺癌杂志,2006,9(4):357-361. 被引量:18
  • 4吴斌,杨志雄,李文,张卫珍.肺癌骨转移的特点和规律的探讨[J].实用肿瘤学杂志,1997,11(1):32-34. 被引量:16
  • 5[2]Susan Haupt1.Apoptosis -the p53 network[J].Journal of Cell Science,2003,116:4077-4085.
  • 6[3]David Lane.How cells choose to die[J].Nature,2001,414:25-26.
  • 7[4]D.Bergamaschi,Y.Samuels,N.J.O'Neil,et al.iASPP oncoprotein is a keyinhibitor of p53 conserved from worm to human[J].Nat Genet,2003,33:162-167.
  • 8[5]Y.Samuels-Lev,D.J.Connor,D.Bergamaschi,et al.ASPP proteins specifically stimulate the apoptotic function of p53[J].Mol Cell,2001,8:781-794.
  • 9[7]IS.Lossos,Y.Natkunam,R.Levy,et al.Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma:correlation with clinical outcome[J].Leuk Lymphoma,2000,43:2309-2317.
  • 10Samuels-Lev Y, Lu X, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Molecular Cell, 2001, 8(4): 781

共引文献12

同被引文献32

  • 1陈娇,张蔚,敖良飞,王丹莉,余珍贵.槲皮素对宫颈癌HeLa细胞STAT3的表达及其信号通路的影响[J].中华临床医师杂志(电子版),2011,5(19):5656-5661. 被引量:8
  • 2Christensen E. Choosing the best endpoint[J].J Hepatol,2008, 49(4) :672- 673.
  • 3Tan B J, Liu Y, Chang K L, et al. Perorally active nanomicellarformulation of quercetin in the treatment of lung cancer[J]. Int J Nanomedicine, 2012,7(6) : 651-661.
  • 4Peixoto P M, Lue J K, Ryu S Y, etal. Mitochondrial apoptosis- induced channel (MAC) function triggers a Bax/Bak-dependent bystander effect[J]. Am J Pathol,2011,178(1) :48-54.
  • 5Zhang Y, Xu X, He P. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells[J].Mol Med Report,2011,4(1) ;25-29.
  • 6Lu H F, Chic Y J, Yang M S, et al. Apigenin induces caspase- dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway[J]. Int J Oncol, 2010,36 (6) : 1477-1484.
  • 7Jin S M, Cho H J, Jung M W, et al. DNA damage-inducing agent-elicited gamma-secretase activity is dependent on Bax/Bcl- 2 pathway but not on caspase cascades[J]. Cell Death Differ, 2007,14( 1 ) : 189-192.
  • 8Nikolovska-Coleska Z, Meagher J L, Jiang S, et al. Interaction of a cyclic, bivalent smac mimetic with the X-linked inhibitor of apoptosis protein[J]. Biochemistry, 2008,47 (37) : 9811-9824.
  • 9Rodriguez-Berriguete G, Galvis L, Fraile B, et al. Immunoreactivity to caspase-3, caspase-7, caspase-8, and easpase-9 forms is frequently lost in human prostate tumors[J]. Hum Pathol,2012,43(2) :229-237.
  • 10Limpaiboon T, Sripa B, Wongkham S, et al. Anti p53 antibodies and p53 protein expression in eholangiocarcinoma[J]. Hepatogastroenterology, 2004,51 (55) : 25-28.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部